DeutschNewstral
Article
thedailyrecord.com on 2018-03-01 16:54
FDA to review Senseonics’ application for diabetes technology
Related news
- MZogenix shares down 23% after FDA refuses to review company’s marketing application for seizure drugmarketwatch.com
FDA to Review Vertex Pharmaceutical’s Application for CRISPR-based Gene Therapy Exa-celjdsupra.com
FDA approves Medtronic’s ‘artificial pancreas’ for diabetesbangordailynews.com- DFDA accepts new diabetes drug application from Boehringer Ingelheim and Eli Lillydailyvoiceplus.com
FDA rejects AstraZeneca's new drug application for blood disorder treatmentbizjournals.com- FDA rejects J&J application for new rheumatoid arthritis treatmentbizjournals.com
- Pittsburgh-based LyGenesis receives FDA clearance for new drug applicationbizjournals.com
- FDA Receives Application for Approval of MDMA-Assisted Therapyjdsupra.com
- FDA accepts Cempra's application for next-gen pneumonia treatmentbizjournals.com
- FDA rejects Vanda’s drug application for jet lag disorderbizjournals.com
- Noveome Biotherapeutics earns FDA designations for new biologic applicationbizjournals.com
- AstraZeneca gets an additional FDA approval for its diabetes drugbizjournals.com
- ASU startup gets FDA clearance for medical simulation technologybizjournals.com
- Albuquerque startup receives FDA approval for its health technologybizjournals.com
MARYLAND NEWS – Gaithersburg teen waiting for FDA approval for his diabetes appdcspotlight.com- MCytoDyn's stock falls after hitting roadblock in FDA application for investigational HIV drugmarketwatch.com
- MBiogen's stock rises on submission to FDA for Alzheimer's drug applicationmarketwatch.com
- FDA Accepts Bio-Thera Solutions’ Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin®jdsupra.com
- MinnMed parent to develop cannabis-based drugs for FDA reviewbizjournals.com
FDA head calls for inquiry into Alzheimer’s drug reviewSeattle Times